Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Altimmune, Inc. | Financial_Report.xls |
EX-32.1 - EXHIBIT 32.1 - Altimmune, Inc. | v230645_ex32-1.htm |
EX-31.1 - EXHIBIT 31.1 - Altimmune, Inc. | v230645_ex31-1.htm |
10-Q - QUARTERLY REPORT - Altimmune, Inc. | v230645_10q.htm |
EX-31.2 - EXHIBIT 31.2 - Altimmune, Inc. | v230645_ex31-2.htm |
Exhibit 32.2
Certification Pursuant to Section 1350 of Chapter 63
of Title 18 of the United States Code
In connection with the Quarterly Report on Form 10-Q of PharmAthene, Inc. (the “Company”) for the quarter ended June 30, 2011, as filed with the Securities and Exchange Commission (the “Report”), I, Charles A. Reinhart III, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
1.1.11.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act.
|
||
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Charles A. Reinhart III
|
|
Charles A. Reinhart III
|
|
Chief Financial Officer
|
|
August 11, 2011
|